Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nithyananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
The order this company entered each market — oldest to newest
Business Development Manager
Indian stock market closes higher, pharma stocks in focus
Sign up to see the full signal feed
How AUROBINDO PHARMA LTD's international expansion compares to its competitors
AUROBINDO PHARMA LTDYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 AUROBINDO PHARMA LTDYou | 0 | 0 | 0% | 0 | 31 |
Business Development Manager
View postingHo Chi Minh City, Vietnam · 5mo ago
Interesting Job Opportunity: Eugia Pharma - Manager - Production QMS
View postingNaidupeta, Andhra Pradesh, India · 5mo ago
Assistant Manager
View postingNaidupeta, Andhra Pradesh, India · 6mo ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Six Nifty 50 companies, including SBI, ITC, Airtel, Hero MotoCorp, Britannia, and Trent, will report Q3 earnings on Thursday. Analysts provide revenue and profit estimates for these companies.
IIFL Finance, Piramal Enterprises, Dalmia Bharat, and others are key stocks to watch. IIFL approves NCD issuance, Piramal faces GST demand, Aditya Birla Real Estate launches successful project.
Several Indian companies including IndiGo, Aurobindo Pharma, and Dabur India are expected to see significant market action due to various corporate developments and financial results.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about AUROBINDO PHARMA LTD's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
